Resources:
• BMS ESG report - https://www.esg.bms.com/assets/bms-esg/us/documents/BMS-ESG-Report-2023.pdf
• DPharm - BMS and the LGBTQ+ Community Improve Clinical Data to Achieve Health Equity (theconferenceforum.org)
• STAT Op Ed - Lack of health data on LGBTQ+ people has serious consequences (statnews.com)
• BMS stories - SOGIIS data: Promoting health equity in clinical trials - Bristol Myers Squibb (bms.com)
About this webinar:
Bristol Myers Squibb (BMS) has successfully enabled patients to self-identify their Sexual Orientation and Gender Identity (SOGI) and intersex status in eligible US clinical trials.
This groundbreaking effort in collecting and operationalizing SOGI data marks a pivotal stride towards addressing the crucial data gap for sexual and gender minorities.
BMS will discuss:
- Navigating and operationalizing SOGI data collection in the clinical research setting
- Addressing challenges and successes in advocating for inclusive data collection within the internal structure of a large organization
- Effective strategies to engage patients and site partners in the process of self-identification
- Initiatives to raise awareness among stakeholders about the importance of inclusive data collection in advancing clinical research